Updates Galore

SPMC, AIRDF, ADUR, LIB.v

South Pacific Hits!

(US: SPMEF | CAD: SPMC)

I don’t have to tell you that I only invest where I think I can have a multi-bagger. So please pay attention when I tell you my only mining investment just hit a winning hole. South Pacific Metals, the first drill hole into the brand-new Megabe target at Ontenu NE, returned 12 m at 3.1 g/t gold from 185 m, including a 1 m hit of 18.1 g/t gold, with 84 g/t silver and copper running up to 1,462 ppm through the zone. Megabe is the corridor between Jorkol and Onki, transected by Otitapa Creek, the same creek the local artisanal miners have been pulling alluvial gold out of for years, which is usually nature’s way of telling you there’s a hard-rock source uphill.

Here’s why I’m leaning in. This isn’t a one-hole story anymore, it’s a corridor story. Onki already gave up a 9.92 g/t gold peak with 2.35% copper, the pathfinder chemistry (the bismuth-telluride signature at Jorkol) reads like the upper levels of an intact epithermal system, and the company is reading a silica cap that says the productive part may still be sitting untested at depth. Gold has now shown up in 7 of 8 holes at Ontenu NE, with two more (Jorkol and a second Megabe hole) pending assay and Ontenu Central, the ~400 m porphyry target, being readied for its first ~600 m test. This is still early-stage, high-risk exploration: true widths are preliminary at roughly 30% of downhole length, and a lot of the corridor is still assays-pending. But for a $24m company that most of the market still isn’t watching, sitting beside a 4-billion-dollar mining operation, the drill core is finally starting to tell the story the geology promised.

Two Releases from Rocket Doctor in a week, one loud and one quiet.

(US: AIRDF | CAD: AIDR)

First, the loud one. Rocket Doctor AI is going racing. The company is partnering with Rick Ware Racing, bringing its brand across the 2026 NASCAR Cup Series, NHRA, Supercross and Flat Track. A physician-built health platform sponsoring a race team is not a pairing most people had on their bingo card, which is exactly what makes it work as a brand play. It is memorable, it is broad, and it puts the name somewhere health-tech companies almost never show up.

Now the quiet one, which is quietly the better deal for your share count. Rocket Doctor’s U.S. subsidiary Treatment.com just had its second year of NIH funding confirmed, from the National Institute on Minority Health and Health Disparities, for an AI family medical history tool it is building with Rush River Research. Year 2 brings in more than US$250,000, pushing total program support past US$500,000, and the whole thing lives inside a competitive grant worth approximately US$2 million in total, now running through May 31, 2027. Here is why a sleepy government grant deserves a minute of your attention: this is non-dilutive money. The government funds the research, and not a single new share gets printed to do it. Treatment also cleared its first-year milestones, leveled up its Global Library of Medicine, and is about to begin pilot testing with acknowledged subject matter experts and identified communities. This update is disseminated by Rocket Doctor AI.

Aduro Clean Tech

(Nasdaq: ADUR | TSX: ACT)

You know I can’t put something out without mentioning Aduro. Instead of stealing his work, I would like to point you to Yazan Homsi’s substack where he did a fabulous job putting the pieces together on the economics of Aduro. Read the substack and give him a follow, he has been the source of some of my best picks.

Yazan Homsi Substack

LibertyStream continues to perform

(TSXV: LIB | US: VLTLF)

They signed a long-term supply offtake agreement with “a leading American industrial partner”. All we really need to know is that it is for 600 tonnes of lithium carbonate per year and also that lithium prices are going through the roof again and have almost tripled since last year. Below is their recent news, so you can get an idea of how fast they are moving.

• March 12, started DLE system installation at its Texas site, targeting early Q2 lithium output.

• March 31, won shareholder backing for its “Texas move,” speeding up the U.S. lithium build-out.

• April 9 , started Texas lithium carbonate output and secured its first U.S. sale. The product is coming off a DLE unit and refining facility at Select Water Solutions’ (NYSE: WTTR) site in Howard County, Texas, north of Midland

• April 13, added a veteran energy banker to the board and approved new equity incentives.

• May 6, announced a “Gen 6” extraction platform, folding 21 months of field and pilot data into a configuration aimed at faster cycle times, less operating variability, better reliability, and on-site lithium carbonate production supporting technical- and battery-grade applications.

I have gotten quite a few emails about these two, so yes, I am still holding both $CISO and $MDNA. The share prices on both are in the gutter, right now.

Disclaimer: This is not investment advice, and I am not an investment advisor. This information is provided for education and entertainment only. Investing is risky. If I am writing about a stock, I personally own it. 45 Degrees Inc. is a related party to me, and you should know that 45 Degrees has a paid marketing agreement with Rocket Doctor AI. Under that agreement, 45 Degrees received an initial fee of US$180,000 and 400,000 stock options exercisable at CAD$0.45 for a six-month term, plus advertising payments of US$25,000 per month for January to March 2026 and US$17,000 for May 2026. The engagement has since been extended through September 2026 at no additional cost.